File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/s00394-019-02119-w
- Scopus: eid_2-s2.0-85074582149
- PMID: 31642984
- WOS: WOS:000492015000005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The lipid-lowering effect of once-daily soya drink fortified with phytosterols in normocholesterolaemic Chinese: a double-blind randomized controlled trial
Title | The lipid-lowering effect of once-daily soya drink fortified with phytosterols in normocholesterolaemic Chinese: a double-blind randomized controlled trial |
---|---|
Authors | |
Keywords | Cholesterol Phytosterol Plant sterol Dyslipidemia LDL |
Issue Date | 2020 |
Publisher | Springer (part of Springer Nature). The Journal's web site is located at http://www.springer.com/steinkopff/journal/394 |
Citation | European Journal of Nutrition, 2020, v. 59 n. 6, p. 2739-2746 How to Cite? |
Abstract | Purpose
Phytosterols reduce intestinal cholesterol absorption and help to lower LDL-cholesterol. Many Chinese adults are lactose-intolerant and cannot tolerate bovine milk enriched with phytosterol. Soya-milk is a common beverage in Asia and it has beneficial effects on general health. We therefore conducted a randomized double-blind controlled trial to assess the effectiveness of a phytosterols-enriched soya drink in lowering serum LDL-cholesterol level (primary outcome) and other cardiovascular parameters (secondary outcomes).
Methods
One hundred and fifty-nine normocholesterolaemic participants (85 men and 74 women; aged 19–79) were randomized to daily intake of one serving of phytosterols-enriched soya drink (N = 82), equivalent to 2 g of phytosterol per day, or a matched soya drink without phytosterols (N = 77) for 3 weeks. Adverse events, withdrawal and compliance were documented.
Results
Among the treatment group (N = 82), phytosterols-enriched soya drink significantly decreased LDL-cholesterol by 5.96% (SE 1.48, 95% CI − 8.91%, − 3.00%) with a median of 6.74% compared with baseline, resulting in a significant reduction of 4.70% (95% CI − 8.89%, − 0.51%; p = 0.028) with a median of 5.20% compared with placebo (N = 77). In contrast, there were no significant changes in other lipid parameters, blood glucose, blood pressure, body weight or waist circumference. Remarkably, 95% of the participants randomized to the fortified drink reported no adverse events at all.
Conclusions
Daily consumption of a phytosterols-enriched soya drink may be a simple and cost-neutral means of lowering LDL-cholesterol in individuals in China, with massive population and rising incidence of coronary heart disease (ClinicalTrials.gov identifier: NCT02881658; date of registration: 14 Aug 2016). |
Persistent Identifier | http://hdl.handle.net/10722/290944 |
ISSN | 2023 Impact Factor: 4.1 2023 SCImago Journal Rankings: 1.167 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chau, YP | - |
dc.contributor.author | Cheng, YC | - |
dc.contributor.author | Sing, CW | - |
dc.contributor.author | Tsoi, MF | - |
dc.contributor.author | Cheng, VKF | - |
dc.contributor.author | Lee, KY | - |
dc.contributor.author | Cheung, CL | - |
dc.contributor.author | Cheung, BMY | - |
dc.date.accessioned | 2020-11-02T05:49:19Z | - |
dc.date.available | 2020-11-02T05:49:19Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | European Journal of Nutrition, 2020, v. 59 n. 6, p. 2739-2746 | - |
dc.identifier.issn | 1436-6207 | - |
dc.identifier.uri | http://hdl.handle.net/10722/290944 | - |
dc.description.abstract | Purpose Phytosterols reduce intestinal cholesterol absorption and help to lower LDL-cholesterol. Many Chinese adults are lactose-intolerant and cannot tolerate bovine milk enriched with phytosterol. Soya-milk is a common beverage in Asia and it has beneficial effects on general health. We therefore conducted a randomized double-blind controlled trial to assess the effectiveness of a phytosterols-enriched soya drink in lowering serum LDL-cholesterol level (primary outcome) and other cardiovascular parameters (secondary outcomes). Methods One hundred and fifty-nine normocholesterolaemic participants (85 men and 74 women; aged 19–79) were randomized to daily intake of one serving of phytosterols-enriched soya drink (N = 82), equivalent to 2 g of phytosterol per day, or a matched soya drink without phytosterols (N = 77) for 3 weeks. Adverse events, withdrawal and compliance were documented. Results Among the treatment group (N = 82), phytosterols-enriched soya drink significantly decreased LDL-cholesterol by 5.96% (SE 1.48, 95% CI − 8.91%, − 3.00%) with a median of 6.74% compared with baseline, resulting in a significant reduction of 4.70% (95% CI − 8.89%, − 0.51%; p = 0.028) with a median of 5.20% compared with placebo (N = 77). In contrast, there were no significant changes in other lipid parameters, blood glucose, blood pressure, body weight or waist circumference. Remarkably, 95% of the participants randomized to the fortified drink reported no adverse events at all. Conclusions Daily consumption of a phytosterols-enriched soya drink may be a simple and cost-neutral means of lowering LDL-cholesterol in individuals in China, with massive population and rising incidence of coronary heart disease (ClinicalTrials.gov identifier: NCT02881658; date of registration: 14 Aug 2016). | - |
dc.language | eng | - |
dc.publisher | Springer (part of Springer Nature). The Journal's web site is located at http://www.springer.com/steinkopff/journal/394 | - |
dc.relation.ispartof | European Journal of Nutrition | - |
dc.rights | This is a post-peer-review, pre-copyedit version of an article published in European Journal of Nutrition. The final authenticated version is available online at: https://doi.org/10.1007/s00394-019-02119-w | - |
dc.subject | Cholesterol | - |
dc.subject | Phytosterol | - |
dc.subject | Plant sterol | - |
dc.subject | Dyslipidemia | - |
dc.subject | LDL | - |
dc.title | The lipid-lowering effect of once-daily soya drink fortified with phytosterols in normocholesterolaemic Chinese: a double-blind randomized controlled trial | - |
dc.type | Article | - |
dc.identifier.email | Sing, CW: cwsing@connect.hku.hk | - |
dc.identifier.email | Cheung, CL: lung1212@hku.hk | - |
dc.identifier.email | Cheung, BMY: mycheung@hkucc.hku.hk | - |
dc.identifier.authority | Cheung, CL=rp01749 | - |
dc.identifier.authority | Cheung, BMY=rp01321 | - |
dc.description.nature | postprint | - |
dc.identifier.doi | 10.1007/s00394-019-02119-w | - |
dc.identifier.pmid | 31642984 | - |
dc.identifier.scopus | eid_2-s2.0-85074582149 | - |
dc.identifier.hkuros | 318470 | - |
dc.identifier.hkuros | 317643 | - |
dc.identifier.volume | 59 | - |
dc.identifier.issue | 6 | - |
dc.identifier.spage | 2739 | - |
dc.identifier.epage | 2746 | - |
dc.identifier.isi | WOS:000492015000005 | - |
dc.publisher.place | Germany | - |
dc.identifier.issnl | 1436-6207 | - |